Biotech Values

[hptaxis]

[Human "Parabiosis"] The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study
https://clinicaltrials.gov/ct2/show/NCT02256306

The PLasma for Alzheimer SymptoM Amelioration (PLASMA) Study: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial of Intravenously-Administered Plasma From Young Donors for Treatment of Mild-To-Moderate Alzheimer's Disease.

Subjects will receive 1 unit of plasma, once weekly for 4 weeks. Subjects will be randomized at a ratio of 1:1 to receive the active treatment during either Block 1 (weeks 0-3) OR Block 2 (weeks 9-12) of study. [1 unit of Plasma From Young Donors (Male, aged 30 or younger).]